{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:17:51Z","timestamp":1767838671118,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2011-0014258"],"award-info":[{"award-number":["2011-0014258"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.neuropharm.2012.07.028","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T11:29:24Z","timestamp":1343388564000},"page":"1028-1041","source":"Crossref","is-referenced-by-count":98,"title":["Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3\u03b2\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"63","author":[{"given":"Hyo Sang","family":"Go","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Jin","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Ja","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seol-Heui","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Ho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.07.028_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2002-36735","article-title":"Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults","volume":"33","author":"Bartholomeusz","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","article-title":"Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells","volume":"65","author":"Bug","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/088307380201700908","article-title":"Clinical and macroscopic correlates of minicolumnar pathology in autism","volume":"17","author":"Casanova","year":"2002","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.58.3.428","article-title":"Minicolumnar pathology in autism","volume":"58","author":"Casanova","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib5","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/brain\/awf189","article-title":"Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes","volume":"125","author":"Castelli","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib6","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1046\/j.1471-4159.1994.63062361.x","article-title":"Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in\u00a0vitro","volume":"63","author":"Chen","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib7","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1128\/MCB.00476-07","article-title":"Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1)","volume":"27","author":"Chen","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1126\/science.1074192","article-title":"Regulation of cerebral cortical size by control of cell cycle exit in neural precursors","volume":"297","author":"Chenn","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2012.07.028_bib10","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2008.07.005","article-title":"Autism, a brain developmental disorder: some new pathopysiologic and genetics findings","volume":"57","author":"Costa e Silva","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.290.3.337","article-title":"Evidence of brain overgrowth in the first year of life in autism","volume":"290","author":"Courchesne","year":"2003","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib12","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2011.1638","article-title":"Neuron number and size in prefrontal cortex of children with autism","volume":"306","author":"Courchesne","year":"2011","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1017\/S0954579405050285","article-title":"Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism","volume":"17","author":"Courchesne","year":"2005","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1423-0127-18-48","article-title":"Valproic acid inhibits neural progenitor cell death by activation of NF-kappaB signaling pathway and up-regulation of Bcl-XL","volume":"18","author":"Go","year":"2011","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ajmg.1477","article-title":"PTEN mutation in a family with Cowden syndrome and autism","volume":"105","author":"Goffin","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpsychires.2004.10.007","article-title":"Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients","volume":"39","author":"Hahn","year":"2005","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/mcne.2002.1117","article-title":"Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons","volume":"20","author":"Hall","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib20","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","article-title":"Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis","volume":"24","author":"Hao","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1469-7610.1997.tb01687.x","article-title":"Annotation: tuberous sclerosis","volume":"38","author":"Harrison","year":"1997","journal-title":"J.\u00a0Child. Psychol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0387-7604(12)80093-3","article-title":"Reduced brainstem size in children with autism","volume":"14","author":"Hashimoto","year":"1992","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development","volume":"11","author":"Hur","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","article-title":"Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism","volume":"22","author":"Ingram","year":"2000","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/toxsci\/kfr070","article-title":"Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells","volume":"121","author":"Jergil","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2121-9-66","article-title":"Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip\/WAF1 pathway","volume":"9","author":"Jung","year":"2008","journal-title":"BMC Cell. Biol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib27","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1242\/jcs.024802","article-title":"Myc increases self-renewal in neural progenitor cells through Miz-1","volume":"121","author":"Kerosuo","year":"2008","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib28","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/sj.onc.1210230","article-title":"A\u00a0hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways","volume":"26","author":"Kim","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib30","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1101\/gad.1021202","article-title":"N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation","volume":"16","author":"Knoepfler","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib31","first-page":"441","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","article-title":"Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature","volume":"98","author":"Kozma","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib33","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1289\/txg.7034","article-title":"Valproic acid teratogenicity: a toxicogenomics approach","volume":"112","author":"Kultima","year":"2004","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/tera.1420350319","article-title":"Teratogen update: valproic acid","volume":"35","author":"Lammer","year":"1987","journal-title":"Teratology"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-7610.2006.01531.x","article-title":"Development in infants with autism spectrum disorders: a prospective study","volume":"47","author":"Landa","year":"2006","journal-title":"J.\u00a0Child. Psychol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0092-8674(00)80354-2","article-title":"Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1","volume":"90","author":"Lijam","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib38","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1016\/j.bmcl.2009.04.040","article-title":"Structure-activity relationship studies of small-molecule inhibitors of Wnt response","volume":"19","author":"Lu","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","article-title":"The cellular neurobiology of depression","volume":"7","author":"Manji","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.neuropharm.2010.09.022","article-title":"Histone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neurons","volume":"60","author":"Marinova","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/bdra.20131","article-title":"Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice","volume":"73","author":"Okada","year":"2005","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib42","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1073\/pnas.82.15.5050","article-title":"Cell-type-specific pattern of myc protooncogene expression in developing human embryos","volume":"82","author":"Pfeifer-Ohlsson","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib43","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1523\/JNEUROSCI.12-11-04565.1992","article-title":"A\u00a0multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes","volume":"12","author":"Reynolds","year":"1992","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib44","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0890-6238(97)80001-U","article-title":"Linking etiologies in humans and animal models: studies of autism","volume":"11","author":"Rodier","year":"1997","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuron.2009.06.006","article-title":"Fgf10 regulates transition period of cortical stem cell differentiation to radial glia controlling generation of neurons and basal progenitors","volume":"63","author":"Sahara","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib50","first-page":"531","article-title":"Nociceptive changes in rats after prenatal exposure to valproic acid","volume":"53","author":"Schneider","year":"2001","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1006369223282","article-title":"Wnt signalling in mammalian development and cancer","volume":"18","author":"Smalley","year":"1999","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib53","first-page":"810","article-title":"Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities","volume":"22","author":"Steen","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib54","article-title":"Epigenetic changes and disturbed neural development in a human embryonic stem cell based model relating to the fetal valproate syndrome","author":"Stiegler","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10803-008-0653-8","article-title":"Regulation of cerebral cortical size and neuron number by fibroblast growth factors: implications for autism","volume":"39","author":"Vaccarino","year":"2009","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib56","doi-asserted-by":"crossref","first-page":"e6086","DOI":"10.1371\/journal.pone.0006086","article-title":"Transcription-independent heritability of induced histone modifications in the mouse preimplantation embryo","volume":"4","author":"VerMilyea","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib57","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/303005","article-title":"Identification of a novel gene on chromosome 7q31 that is interrupted by a translocation breakpoint in an autistic individual","volume":"67","author":"Vincent","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib58","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1046\/j.1471-4159.2003.02276.x","article-title":"Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons","volume":"88","author":"Wang","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib59","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/ar.21232","article-title":"Demethylation of specific Wnt\/beta-catenin pathway genes and its upregulation in rat brain induced by prenatal valproate exposure","volume":"293","author":"Wang","year":"2010","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib60","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0006-8993(02)02362-4","article-title":"A\u00a0role for protein kinase C and its substrates in the action of valproic acid in the brain: implications for neural plasticity","volume":"934","author":"Watterson","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10803-004-2544-y","article-title":"Early indicators of autism spectrum disorders in the second year of life","volume":"34","author":"Wetherby","year":"2004","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A\u00a0male with fetal valproate syndrome and autism","volume":"39","author":"Williams","year":"1997","journal-title":"Dev. Med. Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/417292a","article-title":"A\u00a0common mechanism of action for three mood-stabilizing drugs","volume":"417","author":"Williams","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0968-0004(91)90071-3","article-title":"A\u00a0common denominator linking glycogen metabolism, nuclear oncogenes and development","volume":"16","author":"Woodgett","year":"1991","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib65","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1242\/dev.01881","article-title":"Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways","volume":"132","author":"Yamaguchi","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2012.07.028_bib66","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.yexcr.2008.03.019","article-title":"Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin","volume":"314","author":"Yamauchi","year":"2008","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib67","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/j.yexcr.2007.02.019","article-title":"Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells","volume":"313","author":"Yamauchi","year":"2007","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib68","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1002\/jnr.22460","article-title":"The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-tooth disease-associated mutant Rab7 through the JNK signaling pathway","volume":"88","author":"Yamauchi","year":"2010","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.07.028_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10571-010-9559-z","article-title":"The role of beta-catenin signaling pathway on proliferation of rats neural stem cells after hyperbaric oxygen therapy in\u00a0vitro","volume":"31","author":"Zhang","year":"2011","journal-title":"Cell. Mol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:13:45Z","timestamp":1656069225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0028390812003644"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.028","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}